Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech deals
Biotech
Biopharma M&A more than doubled in Q1 compared to a year ago
There was a record amount of money raised from public offerings and PIPEs in the first quarter of 2024.
Max Bayer
Apr 18, 2024 9:46am
Novartis pays $150M for Arvinas' prostate tumor protein degrader
Apr 11, 2024 8:04am
Merck KGaA signs $1.4B biobuck ADC deal with Caris
Apr 4, 2024 8:25am
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Apr 3, 2024 9:00am
Ipsen joins ADC race via $900M biobuck deal with Sutro
Apr 2, 2024 7:26am
AbbVie grabs a wrench to add immunology-focused Landos Biopharma
Mar 25, 2024 9:20am